NASTAD, in partnership with the National Coalition to Liberate Methadone (NCLM) held the “Part 2: Part 2: Current Methadone Access: Where are we now?” webinar on September 24 . Methadone is an essential tool for saving lives during an overdose crisis and reducing the risk of HIV and hepatitis C...
NASTAD, in partnership with the National Coalition to Liberate Methadone (NCLM) held the “Part 1: History of the Methadone System: How did we get here?” webinar on September 11 . Methadone is an essential tool for saving lives during an overdose crisis and reducing the risk of HIV and hepatitis C...
NASTAD, in partnership with the National Coalition to Liberate Methadone (NCLM) held the “Part 1: History of the Methadone System: How did we get here?” webinar on September 11 . Methadone is an essential tool for saving lives during an overdose crisis and reducing the risk of HIV and hepatitis C...
The National Health and Nutrition Examination Survey (NHANES) underestimates the true prevalence of hepatitis C virus (HCV) infection in the U.S. due to inadequate representation of certain populations. Two models were developed to provide more accurate estimates of HCV prevalence among U.S. adults...
This webinar recording features updates on new hepatitis C prevalence estimates.
This guideline discusses how DBS is a way of gathering a blood sample for hepatitis C testing. With DBS, the person being tested just needs to have a finger pricked, no locating veins or tubes of blood required.
This infographic from HepVu illustrates hepatitis C treatment restrictions in 2024 and how many states have other requirements that reduce access to hepatitis C care.
Hepatitis A, hepatitis B, and hepatitis C are three types of viral hepatitis. Learn how each hepatitis virus affects the liver differently, has different routes of transmission, and has different populations that are commonly affected.
This fact sheet highlights general information about Hepatitis C testing.